Trial intelligence / Profile preview

Metformin in Early Psychosis with Dysglycemia

NCT02167620Phase 4Completed

Sponsor
Center for Addiction and Mental Health
Start
Jun 2014
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM), prediabetes, sponsored by Center for Addiction and Mental Health. Started Jun 2014; status: completed.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)prediabetes

Beyond the preview

Go deeper on NCT02167620.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02167620.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call